Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

UN: World Drug Abuse, Deaths Pretty Stable Over Recent Years

By AP | June 23, 2016

VIENNA (AP) — An estimated quarter of a billion people between the ages of 15 and 64 years, abused at least one drug in 2014 but that figure and the number of drug-related deaths have remained relatively steady over recent years, according to a U.N. report published Thursday.

At the same time, the U.N. Office on Drugs and Crime report said that the number of heroin users in the United States in 2014 was nearly triple that of 2003 with five times as many deaths related to the drug than in 2000.

UNODC put all drug-related fatalities at an estimated 207,400 worldwide in the 15-64 age group while recording a significant drop of poppy cultivation in Afghanistan, the key provider of opium base.

Overall opium production last year fell by 38 percent from the previous year to the late 1990s level of about 4,770 tons, says the report. It attributes that to a 48-percent decline in Afghanistan, “mainly as a result of poor yields” in the south of the country.

The report also notes a slight increase in coca bush cultivation but says the area used for this is the second-smallest since the late 1980s.

Among synthetic drugs, the report said that 75 new psychoactive substances were reported in 2015 with data still being collected for that year. That compares with a total of 66 for all of 2014.

Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news! 


Filed Under: Drug Discovery

 

Related Articles Read More >

EVEREST lead investigator on why Dupixent sets a new bar for treating coexisting CRSwNP and asthma
Sanders, King target DTC pharma ads but the industry worries more about threats to its $2B R&D model
Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE